0.679
price up icon6.26%   0.04
after-market Handel nachbörslich: .65 -0.029 -4.27%
loading
Schlusskurs vom Vortag:
$0.639
Offen:
$0.65
24-Stunden-Volumen:
22,173
Relative Volume:
0.14
Marktkapitalisierung:
$2.64M
Einnahmen:
$2.28M
Nettoeinkommen (Verlust:
$-3.71M
KGV:
-0.2021
EPS:
-3.36
Netto-Cashflow:
$-3.60M
1W Leistung:
+1.34%
1M Leistung:
+29.43%
6M Leistung:
-10.27%
1J Leistung:
-50.07%
1-Tages-Spanne:
Value
$0.65
$0.7028
1-Wochen-Bereich:
Value
$0.62
$0.739
52-Wochen-Spanne:
Value
$0.4575
$1.5499

Nanovibronix Inc Stock (NAOV) Company Profile

Name
Firmenname
Nanovibronix Inc
Name
Telefon
(914) 233-3004
Name
Adresse
969 PRUITT AVE,, TYLER
Name
Mitarbeiter
12
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
NAOV's Discussions on Twitter

Vergleichen Sie NAOV mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
NAOV 0.679 2.64M 2.28M -3.71M -3.60M -3.36
ABT 117.36 202.64B 41.22B 5.77B 6.49B 2.94
SYK 389.40 150.72B 21.97B 3.59B 3.21B 6.74
BSX 90.45 133.82B 15.91B 1.79B 1.89B 0.82
MDT 87.59 112.98B 32.58B 3.93B 5.15B 2.71
EW 69.89 40.52B 6.60B 4.16B 490.10M 2.34

Nanovibronix Inc Aktie (NAOV) Neueste Nachrichten

pulisher
Nov 17, 2024

NanoVibronix Third Quarter 2024 Earnings: US$0.36 loss per share (vs US$0.42 loss in 3Q 2023) - Yahoo Finance

Nov 17, 2024
pulisher
Nov 15, 2024

Armistice Capital, LLC Expands Stake in NanoVibronix Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

NanoVibronix Inc (NAOV) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 12, 2024

NanoVibronix expands global reach, eyes new markets By Investing.com - Investing.com South Africa

Nov 12, 2024
pulisher
Nov 12, 2024

NanoVibronix expands global reach, eyes new markets - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

NanoVibronix Expands Global Reach with NHS Approval, South African Distribution Deal | NAOV Stock News - StockTitan

Nov 12, 2024
pulisher
Oct 16, 2024

A look into NanoVibronix Inc (NAOV)’s deeper side - SETE News

Oct 16, 2024
pulisher
Oct 16, 2024

Ratios in Focus: Analyzing NanoVibronix Inc (NAOV)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Oct 16, 2024
pulisher
Oct 14, 2024

NanoVibronix Inc (NAOV) Stock: A Year of Highs and Lows in the Market - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

NanoVibronix faces potential Nasdaq delisting - Investing.com India

Oct 14, 2024
pulisher
Oct 14, 2024

NanoVibronix faces potential Nasdaq delisting By Investing.com - Investing.com Canada

Oct 14, 2024
pulisher
Oct 11, 2024

NanoVibronix Forges Potential New Distribution Deal - MPO-mag

Oct 11, 2024
pulisher
Oct 09, 2024

NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany - StockTitan

Oct 09, 2024
pulisher
Oct 04, 2024

NanoVibronix stock hits 52-week low at $0.52 - Investing.com India

Oct 04, 2024
pulisher
Oct 04, 2024

NanoVibronix stock hits 52-week low at $0.52 By Investing.com - Investing.com Canada

Oct 04, 2024
pulisher
Sep 26, 2024

NanoVibronix extends CEO and CFO contracts with new terms - Investing.com India

Sep 26, 2024
pulisher
Sep 25, 2024

NanoVibronix Secures Leadership with New Executive Agreements - TipRanks

Sep 25, 2024
pulisher
Sep 24, 2024

NanoVibronix explores UroShield distribution in Israel By Investing.com - Investing.com Australia

Sep 24, 2024
pulisher
Sep 23, 2024

NanoVibronix explores UroShield distribution in Israel - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

NAOVNanoVibronix, Inc. Latest Stock News & Market Updates - StockTitan

Sep 23, 2024
pulisher
Sep 23, 2024

NanoVibronix Signs Letter of Intent with Potential New Distributor - StockTitan

Sep 23, 2024
pulisher
Sep 20, 2024

Novo Nordisk and NanoVation to develop genetic medicines in partnership worth $600m - PMLiVE

Sep 20, 2024
pulisher
Sep 19, 2024

Audit raises transparency concerns in IPO utilisation - The Business Post

Sep 19, 2024
pulisher
Sep 19, 2024

UBC’s NanoVation Therapeutics inks US$600 million deal with Novo Nordisk - BCBusiness

Sep 19, 2024
pulisher
Sep 19, 2024

Novo Nordisk and NanoVation Inked $600M+ Genetic Medicine Deal - Inside Precision Medicine

Sep 19, 2024
pulisher
Sep 19, 2024

NanoVation partners with Novo Nordisk to develop genetic medicines - World Pharmaceutical Frontiers

Sep 19, 2024
pulisher
Sep 18, 2024

Vancouver biotech inks $800M partnership with Novo Nordisk - Business in Vancouver

Sep 18, 2024
pulisher
Sep 18, 2024

NanoVation inks genetic medicines deal with Novo Nordisk - The Pharma Letter

Sep 18, 2024
pulisher
Sep 18, 2024

Novo Nordisk bets $600M biobucks on NanoVation's ability to take genetic medicines beyond the liver - Fierce Biotech

Sep 18, 2024
pulisher
Sep 12, 2024

NanoVibronix (NASDAQ:NAOV) Stock Price Passes Below 50 Day Moving Average of $0.66 - Defense World

Sep 12, 2024
pulisher
Aug 24, 2024

NanoVibronix (NASDAQ:NAOV) Stock Crosses Below 50-Day Moving Average of $0.70 - Defense World

Aug 24, 2024
pulisher
Aug 22, 2024

NanoVibronix (STU:56R0) 5-Day RSI : 39.10 (As of Aug. 22, 2024) - GuruFocus.com

Aug 22, 2024
pulisher
Aug 22, 2024

NanoVibronix (STU:56R0) Momentum Rank : 4 (As of Aug. 22, 2024) - GuruFocus.com

Aug 22, 2024
pulisher
Aug 22, 2024

NanoVibronix (STU:56R0) Float Percentage Of Total Shares Ou - GuruFocus.com

Aug 22, 2024
pulisher
Aug 22, 2024

NanoVibronix (STU:56R0) PE Ratio without NRI : At Loss (As of Aug. 22, 2024) - GuruFocus.com

Aug 22, 2024
pulisher
Aug 21, 2024

NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders - StockTitan

Aug 21, 2024
pulisher
Aug 18, 2024

NAOV (NanoVibronix) Debt-to-Revenue : 0.03 (As of Mar. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

NAOV (NanoVibronix) EPS (Basic) : $-1.69 (TTM As of Mar. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 17, 2024

NanoVibronix Second Quarter 2024 Earnings: US$0.25 loss per share (vs US$0.65 loss in 2Q 2023) - Yahoo Finance

Aug 17, 2024
pulisher
Aug 16, 2024

NanoVibronix (NASDAQ:NAOV) Stock Price Crosses Below 50 Day Moving Average of $0.72 - Defense World

Aug 16, 2024
pulisher
Aug 11, 2024

NanoVibronix (STU:56R0) Short-Term Capital Lease Obligation : €0.04 Mil (As of Jun. 2024) - GuruFocus.com

Aug 11, 2024
pulisher
Aug 08, 2024

NanoVibronix (NASDAQ:NAOV) Stock Passes Below Fifty Day Moving Average of $0.76 - Defense World

Aug 08, 2024
pulisher
Aug 07, 2024

NanoVibronix stock hits 52-week low at $0.58 amid market challenges - Investing.com

Aug 07, 2024
pulisher
Aug 06, 2024

NanoVibronix Inc (NAOV) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle

Aug 06, 2024
pulisher
Aug 06, 2024

Financial Metrics Check: NanoVibronix Inc (NAOV)’s Ratios for Trailing Twelve Months - The Dwinnex

Aug 06, 2024
pulisher
Jul 29, 2024

Short Interest in NanoVibronix, Inc. (NASDAQ:NAOV) Increases By 57.2% - Defense World

Jul 29, 2024
pulisher
Jul 26, 2024

NanoVibronix (NASDAQ:NAOV) Share Price Crosses Below Fifty Day Moving Average of $0.76 - Defense World

Jul 26, 2024
pulisher
Jul 04, 2024

Nanovibronix Inc (NAOV-Q) QuotePress Release - The Globe and Mail

Jul 04, 2024
pulisher
Jun 21, 2024

NanoVibronix Announces Reverse Stock Split - Quantisnow

Jun 21, 2024
pulisher
Jun 11, 2024

NanoVibronix Reports Progress on Three Clinical Trials - Yahoo News UK

Jun 11, 2024
pulisher
Jun 06, 2024

NanoVibronix’s PainShield Included in V.A. Contract - MPO-mag

Jun 06, 2024

Finanzdaten der Nanovibronix Inc-Aktie (NAOV)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices STE
$217.09
price down icon 1.38%
medical_devices ZBH
$113.02
price up icon 0.43%
medical_devices PHG
$25.95
price up icon 0.43%
$76.27
price up icon 0.51%
$82.72
price up icon 1.17%
medical_devices EW
$69.89
price up icon 3.14%
Kapitalisierung:     |  Volumen (24h):